13F

Stock

Biocryst Pharmaceuticals Inc

BCRX · held by 12 managers

Reported value

$62M

Holders

12

+1 new · −0 exited

Holders’ est. mark

−$1.14M

Price effect on 3 books still in the name

Largest holder

$39.5M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY5.2M$39.5MHeld
BANK OF AMERICA CORP /DE/1.9M$14.4MHeld
BARCLAYS PLC782.2K$5.94M−$1.07MCut−$1.27M
CANTOR FITZGERALD, L. P.106.3K$806.9KHeld
TUDOR INVESTMENT CORP ET AL98.2K$745.1KHeld
Sanctuary Advisors, LLC43K$326.6K−$58.9KCut−$69.1K
FARALLON CAPITAL MANAGEMENT LLC24K$182.2KNew
Essential Partners LLC5.04K$38.3K−$6.91KCut−$20.4K
IFP Advisors, Inc689$5.23KHeld
Allworth Financial LP542$4.11KHeld
SkyView Investment Advisors, LLC10.8K$82Held
KBC Group NV6.95K$53Held

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.